홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-Methylpiperazine → 1-(3-Methoxy-5-nitrophenyl)-4-methylpiperazine

HRID 631
인쇄

반응식

HRID 631 반응식
CN1CCNCC1.COc1cc(Br)cc([N+](=O)[O-])c1>CC(=O)O.CC(=O)O.Cc1ccccc1.O=C([O-])[O-].[Cs+].[Cs+].[Pd].c1ccc(P(c2ccccc2)c2ccc3ccccc3c2-c2c(P(c3ccccc3)c3ccccc3)ccc3ccccc23)cc1>COc1cc(N2CCN(C)CC2)cc([N+](=O)[O-])c1
참가 물질반응 조건실험 절차출처 및 근거반응 노트

참가 물질

7

반응물 2

HCID 531671-MethylpiperazineHCID 122990761-Bromo-3-methoxy-5-nitrobenzene

생성물 1

HCID 666427351-(3-Methoxy-5-nitrophenyl)-4-methylpiperazine수율 71.17%

시약·촉매·용매 4

HCID 10796Cesium carbonate시약HCID 634876Binap, (A+-)-촉매HCID 4144353Palladium (II) acetate촉매

반응 조건

온도
150 °C

실험 절차

1-bromo-3-methoxy-5-nitrobenzene (116 mg, 0.5 mmol), 1-methylpiperazine (167 µl, 1.50 mmol), Palladium(II) acetate (11.23 mg, 0.05 mmol), BINAP (31.1 mg, 0.05 mmol), Cs2CO3 (326 mg, 1.00 mmol) and PhCH3 (10 mL) were added to a 100ml rb flask and heated at 150 °C for 1h. LCMS showed rxn done with desired product formed. Rxn was filtered and concentrated. The residue was purified by Gilson (CH3CN/Water 0-50% + 0.1%TFA) to get the desired product 1-(3-methoxy-5-nitrophenyl)-4-methylpiperazine (130 mg, 71.2 %).

출처 및 근거

ORD 기록
ord-088bd21d086a43258b728521904f368d
출처 데이터셋
750 AstraZeneca ELN dataset
원본 링크
출처 보기

반응 노트

이 페이지에서참가 물질반응 조건실험 절차출처 및 근거반응 노트
HCID 1140
Toluene
용매